We are live on
!
Find out more
OptimizeRx
OPRX
OPRX
128 hedge funds and large institutions have $205M invested in OptimizeRx in 2022 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 37 increasing their positions, 42 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
871% more call options, than puts
Call options by funds: $14.7M | Put options by funds: $1.52M
9.58% less ownership
Funds ownership: 86.08% → 76.5% (-9.6%)
12% less repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 42
13% less funds holding
Funds holding: 147 → 128 (-19)
42% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 45
52% less capital invested
Capital invested by funds: $428M → $205M (-$224M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
128
Holders Change
-19
Holders Change %
-12.93%
% of All Funds
2.2%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
26
Increased
37
Reduced
42
Closed
45
Calls
$14.7M
Puts
$1.52M
Net Calls
+$13.2M
Net Calls Change
-$2.25M
Top Buyers
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$8.04M |
| 2 |
Millennium Management
New York
|
+$6.15M |
| 3 |
Two Sigma Advisers
New York
|
+$4.69M |
| 4 |
Two Sigma Investments
New York
|
+$4.08M |
| 5 |
IP
Invenire Partners
Ridgefield,
Connecticut
|
+$2.08M |
